Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors

Blood

Volumn 105, Issue 1, 2005, Pages 85-94

  Leberbauer, Cornelia ^b   Boulmé, Florence ^b   Unfried, Gertrud ^b   Huber, Johannes ^b   Beug, Hartmut ^b   Müllner, Ernst W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; GLUCOCORTICOID; HORMONE RECEPTOR; LIOTHYRONINE; STEROID; THYROID HORMONE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL SIZE; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 11144224801     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1002     Document Type: Article

References (84)

1. Bauer A, Gandrillon O, Samarut J, Beug H. Nuclear receptors in hematopoietic development: cooperation with growth factor receptors in regulation of proliferation and differentiation. In: Zon L, ed. Hematopoiesis: A Developmental Approach. Oxford, UK: Oxford University Press; 2001:268-290.
2. Dolznig H, Boulme F, Stangl K, et al. Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J. 2001;15:1442-1444.
3. Dolznig H, Habermann B, Stangl K, et al. Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts. Curr Biol. 2002;12:1076-1085.
4. Kolbus A, Pilat S, Husak Z, et al. Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J Exp Med. 2002;196:1347-1353.
5. Kolbus A, Blazquez-Domingo M, Carotta S, et al. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood. 2003;102:3136-3146.
6. Schmidt U, van den Akker E, Parren-van Amelsvoort M, et al. Btk is required for an efficient response to Erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors. J Exp Med. 2004;199:785-795.
7. Muta K, Krantz SB, Bondurant MC, Wickrema A. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest. 1994;94:34-43.
8. Wu H, Klingmuller U, Besmer P, Lodish HF. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 1995;377:242-246.
9. Kapur R, Zhang L. A novel mechanism of cooperation between c-Kit and erythropoietin receptor: stem cell factor induces the expression of Stats and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin. J Biol Chem. 2001;276:1099-1106.
10. Bauer A, Tronche F, Wessely O, et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 1999;13:2996-3002.
11. Deiner EM, Dolznig H, Kolbus A, et al. Normal erythroid progenitor renewal: essential players and functions revealed by cells from genetically modified mice. Under revision. 2003.
12. von Lindern M, Deiner EM, Dolznig H, et al. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. Oncogene. 2001;20:3651-3664.
13. Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J. 1998;17:4291-4303.
14. von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood. 1999;94:550-559.
15. Neildez-Nguyen TM, Wajcman H, Marden MC, et al. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nat Biotechnol. 2002;20:467-472.
16. Barker JN, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer. 2003;3:526-532.
17. Isoyama K, Ohnuma K, Kato K, et al. Cord blood transplantation from unrelated donors: a preliminary report from the Japanese Cord Blood Bank Network. Leuk Lymphoma. 2003;44:429-438.
18. Issaragrisil S. Stem cell transplantation for thalassemia. Int J Hematol. 2002;76(suppl 1):307-309.
19. Barker JN, Wagner JE. Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol. 2002;14:160-164.
20. Rogers I, Casper RF. Stem cells: you can't tell a cell by its cover. Hum Reprod Update. 2003;9:25-33.
21. Lawlor GF, Tauchi T, Ohyashiki K, Matsumiya T. Enriched levels of erythropoietin in human umbilical cord blood stimulate hematopoietic progenitor cells. J Biochem Mol Biol Biophys. 2002;6:65-70.
22. Fuerstenberg S, Leitner I, Schroeder C, Schwarz H, Vennstrom B, Beug H. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype. EMBO J. 1992;11:3355-3365.
23. Hayman MJ, Meyer S, Martin F, Steinlein P, and Beug H. Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors. Cell. 1995;74:157-169.
24. Beug H, Palmieri S, Freudenstein C, Zentgraf H, Graf T. Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus. Cell. 1982;28:907-919.
25. Kowenz E, Leutz A, Doderlein G, Graf T, Beug H. ts-oncogene-transformed erythroleukemic cells: a novel test system for purifying and characterizing avian erythroid growth factors. Hamatol Bluttransfus. 1987;31:199-209.
26. Mikulits W, Dolznig H, Edelmann H, et al. Dynamics of cell cycle regulators: artifact-free analysis by recultivation of cells synchronized by centrifugal elutriation. DNA Cell Biol. 1997;16:849-859.
27. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621.
28. Burgess W, Jesse K, Tang Q, Broussard SR, Dantzer R, Kelley KW. Insulin-like growth factor-1 and the cytokines IL-3 and IL-4 promote survival of progenitor myeloid cells by different mechanisms. J Neuroimmunol. 2003;135:82-90.
29. Kelley KW, Meier WA, Minshall C, et al. Insulin growth factor-1 inhibits apoptosis in hematopoietic progenitor cells: implications in thymic aging. Ann N Y Acad Sci. 1998;840:518-524.
30. Sanders M, Sorba S, Dainiak N. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp Hematol. 1993;21:25-30.
31. Vicent GP, Pecci A, Ghini A, Piwien-Pilipuk G, Galigniana MD. Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses. Exp Cell Res. 2002;276:142-154.
32. Kauppi B, Jakob C, Farnegardh M, et al. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem. 2003;278:22748-22754.
33. Migliaccio G, Di Pietro R, di Giacomo V, et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002;28:169-180.
34. Panzenbock B, Bartunek P, Mapara MY, Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood. 1998;92:3658-3668.
35. Steinlein P, Wessely O, Meyer S, Deiner EM, Hayman MJ, Beug H. Primary, self-renewing erythroid progenitors develop through activation of both tyrosine kinase and steroid hormone receptors. Curr Biol. 1995;5:191-204.
36. de Jong MO, Westerman Y, Wagemaker G, Wognum AW. Coexpression of Kit and the receptors for erythropoietin, interleukin 6 and GM-CSF on hemopoietic cells. Stem Cells. 1997;15:275-285.
37. Fornas O, Domingo JC, Marin P, Petriz J. Flow cytometric-based isolation of nucleated erythroid cells during maturation: an approach to cell surface antigen studies. Cytometry. 2002;50:305-312.
38. Auffray I, Marfatia S, de Jong K, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood. 2001;97:2872-2878.
39. + cells. Blood Cells Mol Dis. 1999;25:141-146.
40. Orwoll ES, Orwoll RL. Hematologic abnormalities in patients with endocrine and metabolic disorders. Hematol Oncol Clin North Am. 1987;1:261-279.
41. Schroeder C, Gibson L, Nordstrom C, Beug H. The estrogen receptor cooperates with the TGF alpha receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal. EMBO J. 1993;12:951-960.
42. Wessely O, Bauer A, Quang CT, et al. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor. Biol Chem. 1999;380:187-202.
43. von Lindern M, Boer L, Wessely O, Parker M, Beug H. The transactivation domain AF-2 but not the DNA-binding domain of the estrogen receptor is required to inhibit differentiation of avian erythroid progenitors. Mol Endocrinol. 1998;12:263-277.
44. Neumann F. The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research. Exp Clin Endocrinol. 1994;102:1-32.
45. 1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control. Cell Growth Differ. 1995;6:1341-1352.
46. Killisch I, Steinlein P, Romisch K, Hollinshead R, Beug H, Griffiths G. Characterization of early and late endocytic compartments of the transferrin cycle: transferrin receptor antibody blocks erythroid differentiation by trapping the receptor in the early endosome. J Cell Sci. 1992;103:211-232.
47. Carmel R, Spencer CA. Clinical and subclinical thyroid disorders associated with pernicious anemia: observations on abnormal thyroid-stimulating hormone levels and on a possible association of blood group O with hyperthyroidism. Arch Intern Med. 1982;142:1465-1469.
48. Das KC, Mukherjee M, Sarkar TK, Dash RJ, Rastogi GK. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab. 1975;40:211-220.
49. Schroeder C, Gibson L, Zenke M, Beug H. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action. Oncogene. 1992;7:217-227.
50. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851-857.
51. Cole TJ, Blendy JA, Monaghan AP, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995;9:1608-1621.
52. Tronche F, Kellendonk C, Reichardt HM, Schutz G. Genetic dissection of glucocorticoid receptor function in mice. Curr Opin Genet Dev. 1998;8:532-538.
53. Wessely O, Deiner EM, Beug H, von Lindern M. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J. 1997;16:267-280.
54. Reichardt HM, Kaestner KH, Tuckermann J, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998;93:531-541.
55. + cell-enriched hematopoietic cell population from human umbilical cord blood in response to recombinant cytokines. Arch Med Res. 2002;33:107-114.
56. Bruno E, Horrigan SK, Van Den Berg D, et al. The SmadS gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood. 1998;91:1917-1923.
57. Zermati Y, Fichelson S, Valensi F, et al. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol. 2000;28:885-894.
58. Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation. Stem Cells. 2003;21:557-567.
59. - cells: correlation between long-term culture-initiating cells and telomerase expression. Leukemia. 1998;12:728-734.
60. Kie JH, Jung YJ, Woo SY, et al. Ultrastructural and phenotypic analysis of in vitro erythropoiesis from human cord blood CD34(+) cells. Ann Hematol. 2003;27:278-283.
61. Ellis TM, Moser MT, Le PT, Flanigan RC, Kwon ED. Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice. Int Immunol. 2001;13:553-558.
62. Malgor LA, Valsecia M, Verges E, De Markowsky EE. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Acta Physiol Pharmacol Ther Latinoam. 1998;48:99-105.
63. Saitoh T, Morimoto K, Kumagai T, Tsuboi I, Aikawa S, Horie T. Comparison of erythropoietic response to androgen in young and old senescence accelerated mice. Mech Ageing Dev. 1999;109:125-139.
64. Claustres M, Sultan C. Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures. Horm Res. 1988;29:17-22.
65. Khetawat G, Faraday N, Nealen ML, et al. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Blood. 2000;95:2289-2296.
66. Migliaccio A, Piccolo D, Castoria G, et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 1998;17:2008-2018.
67. Honer C, Nam K, Fink C, et al. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol. 2003;63:1012-1020.
68. Schoenmakers E, Verrijdt G, Peeters B, Verhoeven G, Rombauts W, Claessens F. Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem. 2000;275:12290-12297.
69. Verhoeven G, Swinnen JV. Indirect mechanisms and cascades of androgen action. Mol Cell Endocrinol. 1999;151:205-212.
70. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in non-genomic androgen actions. Mol Endocrinol. 2002;16:2181-2187.
71. Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000;85:2670-2677.
72. Weber JP, Walsh PC, Peters CA, Spivak JL. Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men. Am J Hematol. 1991;36:190-194.
73. Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am J Kidney Dis. 1991;17:29-33.
74. Dickerman RD, Pertusi R, Zachariah NY, Schaller F. Androgen-induced erythrocytosis. Am J Hematol. 1998;59:263-264.
75. Fried W, Gumey CW. The erythropoietic-stimulating effects of androgens. Ann N Y Acad Sci. 1968;149:356-365.
76. Alexanian R. Erythropoietin and erythropoiesis in anemic man following androgens. Blood. 1969;33:564-572.
77. Kennedy BJ, Gilbertsen AS. Increased erythropoiesis induced by androgenic-hormone therapy. N Engl J Med. 1957;256:719-726.
78. Kennedy BJ, Nathanson IT, Tibbetts DM, Aub JC. Biochemical alterations during steroid hormone therapy of advanced breast cancer. Am J Med. 1955;19:337-349.
79. Oppenheimer JH. Thyroid hormone action at the nuclear level. Ann Intern Med. 1985;102:374-384.
80. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev. 1993;14:184-193.
81. Forrest D, Erway LC, Ng L, Altschuler R, Curran T. Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet. 1996;13:354-357.
82. Fraichard A, Chassande O, Plateroti M, et al. The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J. 1997;16:4412-4420.
83. Wikstrom L, Johansson C, Salto C, et al. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1. EMBO J. 1998;17:455-461.
84. Bauer A, Ulrich E, Andersson M, Beug H, von Lindern M. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction. Oncogene. 1997;15:701-715.